Pasquale Mordasini MD, MScHead of the Neurointerventional Unit
University Institute of Diagnostic and Interventional NeuroradiologyUniversity Hospital Inselspital BernDirector and Chair: Prof. J. Gralla
Are IV lytics for LVO patients presentingdirectly at thrombectomy centers
necessary?European Course in Interventional Neuroradiology, 1st Cycle Module 1 on
Ischemic Stroke, Barcelona, April 29, 2019
2
Is IVTbeneficial prior to
mechanical thrombectomy?
3
Arguments pro bridging
1. rtPA can be started earlier («ship-and-drip»)
2. rtPA may facilitate recanalization (enzymatic digestion)
3. rtPA may improve reperfusion of small vessels(lysis of smaller distal thrombus fragments, microvascular thrombosis)
4. Mechanical thrombectomy may be delayed or not feasible
4
Arguments against bridging
1. rtPA poor recanalization rates in large vessel occlusion2. rtPA narrow time window with decreasing efficacy3. rtPA absolute/relative contraindications 4. rtPA (relative) contraindication for IA
lytics/antiplatelets/heparin5. rtPA increases risk of hemorrhage6. rtPA may produce thrombus dislocation7. rtPA impact on health care costs8. rtPA may cause life-threatening complications9. rtPA may delay EVT in some patients
5
Two cohorts of patients
Stroke Center
Stroke UnitIVT
MT
„Drip & Ship“
6
Two cohorts of patients
Stroke Center
Stroke UnitIVT
IVT MT
„Drip & Ship“ „Mothership“
7
Two cohorts of patients
Stroke Center
Stroke UnitIVT
IVT MT
„Drip & Ship“ „Mothership“
8
Bridging‘Believers’
Bridging‘Non-Believers’
Literature
9
1) Preinterventional Reperfusion
2) Reperfusion Success
3) Symptomatic Intracerebral Hemorrhage
Major arguments
10
1) Preinterventional Reperfusion
2) Reperfusion Success
3) Symptomatic Intracerebral Hemorrhage
Major arguments
11
1. Preinterventional ReperfusionPrevalence
Tsivgoulis et al. Stroke 2017
11%
Pre-treatment with rtPA in LVO stroke eligible for mTE results in successful reperfusion in 1 of 10 cases.
Prevalence of reperfusion prior to EVT
Dripp-p-andd-d-Ship
MothershipM1M
M2MM
ICA Thrombus s length
Time e tooo angio
12
1. Preinterventional ReperfusionTime dependency
Mueller et al. EJON 2017
13
Overall change of occlusion site (COS) 10.7% in 720 endovascular candidates, subdividing into:
• 2.7% COS with TICI 0/1
• TICI 2a )
• 1.8% COS with perfusion worsening
1. Preinterventional ReperfusionWhat about mothership only?
Kaesmacher et al. Stroke 2018 14
Factors related to change of occlusion site (COS) with TICI 2a in 720 endovascular candidates
• thrombus length (1mm aOR 0.926, 95%-CI 0.87-0.99)
• cardioembolic thrombus (aOR 2.3, 95%-CI 1.1-4.6)
• IV-tPA (aOR 11.98, 95%-CI 4.5-31.6)
1. Preinterventional ReperfusionWhat about mothership only?
Kaesmacher et al. Stroke 2018
15
1. Preinterventional ReperfusionAlways beneficial?
16
Factors related to change of occlusion site (COS) with perfusion worsening
• Higher admission NIHSS (aOR 1.10 95%-CI 1.01-1.21)
• Carotid-T occlusion (aOR 18.62 95%-CI 3.77-92.00)
• IV tPA (4.33, 95%-CI 1.12-16.80)
1. Preinterventional ReperfusionAlways beneficial?
Kaesmacher et al. Stroke 2018
17
1) Preinterventional Reperfusion
2) Reperfusion Success
3) Symptomatic Intracerebral Hemorrhage
Major arguments
18
• Meta-analysis including 20 studies with 5279 patients
Kaesmacher et al. JNIS 2018
IVT + MT vs dMTdMT in IVT eligible pts
dMT in IVT ineligible pts
19
2. Reperfusion SuccessTICI 2b/3
- 19/20 studies- 4220 patients
IVT-eligibledMTE patientsIVT-ineligibledMTE patients
Kaesmacher et al. JNIS 2018
• Overall, non-significant different rates of successful reperfusion
• Non-significant trend for higher rates of successful reperfusion in IVT eligible pts.
20
- 9/20 studies- 1753 patients
no effect
2. Reperfusion SuccessTICI 3
Kaesmacher et al. JNIS 2018
21
1) Preinterventional Reperfusion
2) Reperfusion Success
3) Symptomatic Intracerebral Hemorrhage
Major arguments
22
3. Symptomatic ICHFactors related to sICH in EVT
• Cardioembolic Stroke
• Poor collaterals
• Delayed treatment
• High ASPECTS
• Diabetes
• High NIHSS
Jiang et al. PLOS ONE 2015; Hao et al. JNIS 2018; Kaesmacher et al Cerebrovasc Dis 2017
23
- 16/20 studies- 3903 patients
IVT-eligibledMTE patientsIVT-ineligibledMTE patients
3. Symptomatic ICH
Kaesmacher et al. JINS 2018
• Overall, non-significant trend for higher rates of sICH in IVT + MTE
• No treatment group effect
24
Preinterventional Reperfusion
ReperfusionSuccess
SymptomaticICH
Outcome?
25
OutcomeTreatment effect size of MT
Goyal et al. Lancet 2016 26
OutcomeFunctional independence
- 17/20 studies- 4657 patients
IVT-eligibledMTE patientsIVT-ineligibledMTE patients
Kaesmacher et al. JNIS 2018
• Overall, non-significant trendfor lower rates of functionaloutcome in dMT
• dMT IVT-E: no difference in rates of functional outcome
• dMT IVT-IN: non-significanttrend for lower rates offuncitonal outcome
27
OutcomeSame same, but different
• CAVE: Selection!
Atrial fibrillation Previous CVI
Kaesmacher et al. JNIS 2018
Prevalence of risk factors in dMT studies compared to bridging studies
28
Individualized decision against t-PA?
• Mothership (Angio team ready) dependency of IVT efficacy !
• Carotid-T, large thrombilow efficacy + risk of perfusion worsening
• Microbleeds, striatal infarction, diabetic, high ASPECTSsICH
• Tandem sICH, antiplatelet medication
29
Summary of evidence• Best evidence for bridging benefit:
pre-interventional reperfusion
• No evidence for facilitation of mechanical reperfusion
• Available literature on outcome comparison is severlybiased, the quality of evidence regarding the relative merits of IVT + MT versus dMTE is low
• Considering proximal large vessel occlusions:substantial indications for non-inferiorityweak indications for superiorityclinical equipoise»
30
Is this relevant?
• Maybe we can achieve equal recanalizationresults!
• Maybe we can decrease rates of hemorrhages!
• Maybe we can avoid thrombus migration!
• Maybe we have similar (or even better?) outcome!
• Maybe we can reduce costs by skipping rtPA!
31
Cohorts Mothership MothershipOcclusion Site ICA, M1 +/- Tandem ICA, M1, proximal M2NIHSSAgeSample Size 404 540Design Non-inferiority SuperiorityStart 10/2017 01/2018Countries Switzerland, France, Germany,
Spain, Canada, FinlandNetherlands
Ongoing Randomized controlled Trials
- Direct MT (China), Direct safe (Australia), SKIP study (Japan)
32
Conclusion
• IVT will remain the standard of care for all patients with peripheral intracranial vessel occlusion
33
Conclusion
• IVT will remain the standard of care for all patients with peripheral intracranial vessel occlusion
• But a trial is needed comparing direct mechanical thrombectomy versus bridging thrombolysis in patients with:
–proximal vessel occlusion in the anterior circulation–which can immediately be treated by endovascular therapy
34
Thank you!• www.strokecenter.ch• http://www.neurologie.insel.ch/de/unser-angebot/stroke-center/stroke-richtlinien/